Click a link below to view the mailing archive as if it had been sent to you.
| 2022-02-28 12:15 | | Bristol Myers' Opdivo steps in FDA fast lane for potential first-in-class nod in pre-surgery lung cancer and more... |
| 2022-02-28 00:15 | | Ukraine: industry-sponsored clinical development at risk and more... |
| 2022-02-25 12:15 | | Eli Lilly, Boehringer Ingelheim's Jardiance clinches heart failure edge with FDA nod for wider label and more... |
| 2022-02-25 00:15 | | Sanofi signals a big interest in oncology as it adds a cancer R&D star to the board and more... |
| 2022-02-24 12:15 | | Merck cuts ties to Moderna's early-phase KRAS vaccine, leaving mRNA specialist to mull next steps and more... |
| 2022-02-24 00:15 | | Roche's gene therapy unit finds a new Spark as co-founding CEO makes way for new leader and more... |
| 2022-02-23 12:15 | | Sanofi and GSK ready to seek authorization for COVID-19 vaccine and more... |
| 2022-02-23 00:15 | | Baxter warns of potential blockages in infusion pumps linked to 3 deaths and more... |
| 2022-02-22 12:15 | | GlaxoSmithKline unveils Haleon, the new brand name for its outgoing consumer health unit and more... |
| 2022-02-21 12:15 | | Sackler family owners of Purdue Pharma propose up to $6 billion opioid settlement and more... |
| 2022-02-20 12:15 | | Merck’s Anti-Covid Pill Shows Better Effectiveness In Indian Study and more... |
| 2022-02-18 12:15 | | Sanofi's Dupixent falls short in phase 3 chronic spontaneous urticaria trial and more... |
| 2022-02-18 00:15 | | GSK launches trade secrets case against former employee, ordering data and property to be returned 'in one piece' and more... |
| 2022-02-17 12:15 | | Powerful pack of senators pushes DOJ for a criminal probe of Sacklers' role in opioid epidemic and more... |
| 2022-02-17 00:15 | | 3 more deaths among patients on Biogen's Aduhelm fuel safety concerns, though no link established: analyst and more... |
| 2022-02-16 12:15 | | How can pharma avoid HCP 'promo fatigue'? With synchronized campaigns and storytelling and more... |
| 2022-02-16 00:15 | | Califf confirmed as FDA chief in close vote, ending protracted vacancy at health agency and more... |
| 2022-02-15 12:15 | | Latest data on Bayer's Essure show more patients had device removed: FDA and more... |
| 2022-02-15 00:15 | | Trial win sets up new use for Astellas, Seagen’s Padcev in bladder cancer and more... |
| 2022-02-14 12:15 | | Merck restructures to strengthen CDMO business and more... |
| 2022-02-13 00:15 | | Pfizer stalls COVID-19 vaccine app as it awaits data on third dose in young kids and more... |
| 2022-02-11 12:15 | | Lilly back in COVID-19 antibody game with $720 million deal with U.S. for omicron-busting hopeful and more... |
| 2022-02-11 00:15 | | FDA sends signal with tough questions of Lilly at cancer drug meeting and more... |
| 2022-02-10 12:15 | | AstraZeneca dumps late-phase, next-gen COVID-19 vaccine, calling time on a beta player in an omicron world and more... |
| 2022-02-10 00:15 | | Teva execs claim mixed winning streak in pricey opioids court battle — as permanent peace remains elusive and more... |
| 2022-02-09 12:15 | | China-Developed Drugs for U.S. Market Could Face Steep Hill and more... |
| 2022-02-09 00:15 | | J&J pauses COVID-19 vaccine production at Dutch plant in temporary pivot to RSV shot: NYT and more... |
| 2022-02-08 12:15 | | Pfizer's Covid-19 vaccine captures the most annual sales of any medical product ever — by more than $15B and more... |
| 2022-02-08 00:15 | | AstraZeneca Will Ax Its U.S. Workers’ Pension Plan This Year and more... |
| 2022-02-07 12:15 | | CVS to bring late-stage clinical trials to certain locations in push to serve underrepresented patients and more... |
| 2022-02-06 00:15 | | Will a New FDA-Approved COVID Pill Propel This Healthcare Company's Stock? and more... |
| 2022-02-05 00:15 | | Sanofi's Dupixent rolls on, but US flu shots took backseat to COVID-19 boosters in the fourth quarter and more... |
| 2022-02-04 12:15 | | Bristol busy boosting supply of Breyanzi, Abecma as massive Revlimid patent cliff looms and more... |
| 2022-02-04 00:15 | | Lilly slows FDA submission of Alzheimer's drug after Medicare decision and more... |
| 2022-02-03 12:15 | | After disastrous start to launch, Biogen still expects 'minimal' sales from Aduhelm this year and more... |
| 2022-02-03 00:15 | | Justice Department’s False Claims Act Settlements and Judgments Exceed $5.6 Billion in Fiscal Year 2021 and more... |
| 2022-02-02 12:15 | | Novartis says Leqvio launch will feature a 'modest initial ramp,' but blockbuster potential awaits and more... |
| 2022-02-02 00:15 | | The pipeline of new antibiotics is drying up. A bill in Congress aims to change that. and more... |
| 2022-02-01 12:15 | | COVID-19 vaccine for young kids could be ready this month and more... |
| 2022-02-01 00:15 | | Novavax finally submits its COVID-19 vaccine to the FDA. Is it too late? and more... |
